Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00524290 · ClinicalTrials.gov registry record
Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 100
- Enrollment target
NCT00524290 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 100 participants.
The verdict
NCT00524290 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The objectives of this multinational study are to assess the clinical outcomes of patients with Acinetobacter bloodstream infection and to further assess the predictors of mortality in this patient population. We also aim to characterize the molecular epidemiology of this remarkable organism in an attempt to further understand its transmission dynamics on a global level and to determine whether increased pathogenicity is geographically dependent.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2009-04 |
| Est. Completion | 2017-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00524290
The ClinicalTrials.gov registry entry for NCT00524290 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00524290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00524290 about?
NCT00524290 is a clinical study titled "Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol". The objectives of this multinational study are to assess the clinical outcomes of patients with Acinetobacter bloodstream infection and to further assess the predictors of mortality in this patient population. We also aim to characterize the molecular epidemiology of this remarkable organism in an a...
What is the current status of trial NCT00524290?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2009-04. Estimated completion is 2017-12.
Who is sponsoring clinical trial NCT00524290?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.